Sagimet Biosciences (SGMT) EPS (Basic) (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly EPS (Basic) of -$0.42 for Q1 2026, up 31.68% year-over-year from -$0.32 in Q1 2025, and down 2.69% quarter-over-quarter from -$0.41 in Q4 2025.
Sagimet Biosciences (SGMT) EPS (Basic) (2022 - 2026) Analysis & Trends
Sagimet Biosciences' EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.42 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 31.68% year-over-year to -$0.42; the TTM figure through Mar 2026 stood at -$2.15 (up 46.73% YoY), while the FY2025 annual figure was -$1.7, up 52.53% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.42, down from -$0.41 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.3 in Q1 2024, with the low at -$298.07 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.87 (2023), against an average of -$35.8.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) tumbled 277.09% in 2023, then soared 99.78% in 2024.
- Sagimet Biosciences' EPS (Basic) stood at -$298.07 in 2022, then jumped by 99.65% to -$1.04 in 2023, then plunged by 152.68% to -$2.63 in 2024, then soared by 84.31% to -$0.41 in 2025, then retreated by 2.69% to -$0.42 in 2026.
- Business Quant data shows SGMT's EPS (Basic) at -$0.42 in Q1 2026, -$0.41 in Q4 2025, and -$0.61 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.52 |
| Mar 31, 2026 | -0.42 |
| Dec 31, 2025 | -0.41 |
| Sep 30, 2025 | -0.61 |
| Jun 30, 2025 | -0.71 |
| Mar 31, 2025 | -0.62 |
| Dec 31, 2024 | -2.63 |
| Sep 30, 2024 | -0.51 |
| Jun 30, 2024 | -0.33 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | -1.04 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -149.63 |
| Mar 31, 2023 | -36.16 |
| Dec 31, 2022 | -298.07 |
| Sep 30, 2022 | -40.35 |
| Jun 30, 2022 | -39.68 |